1.Epidermolysis Bullosa Pruriginosa in a 12-year-old male: A case report
Agustin Miguel P. Soriano ; Mae Ramirez-Quizon
Journal of the Philippine Medical Association 2024;102(2):81-88
Introduction:
Epidermolysis Bullosa Pruriginosa (EBP) is a rare subtype of the inherited Dystrophic ~ Epidermolysis Bullosa spectrum of diseases and results from a gene mutation in COL7AL Though predominantly an autosomal dominant disease, autosomal recessive and even sporadic have been reported.
Case Summary:
Case Summary:We report a case of a 12-year-old Filipino male presenting with a chronic history of numerous scratching-induced blisters predominantly distributed on the extensor aspect of his arms and legs without concomitant oral lesions, nail dystrophy, or hair findings, and without a family history of similar lesions. Histopathologic assessment, Direct Immunofluorescence (DIF), and Indirect Immunofiuorescence (IIF) showed a subepidermal split with scant inflammatory infiltrates, no immunofluorescence, and absent userrated linear immunofluorescence at the dermal-side of the Salt Split Skin slide, respectively, which were all consistent with EBP. Enzyme-Linked Immunosorbent Assay (ELISA) for Anti-Collagen VII antibodies was slightly elevated, which may suggest an alternative diagnosis of Epidermolysis Bullosa Acquisita (EBA). This slight elevation may be due to the mutated Collagen Vil protein becoming antigenic and therefore provoking an immune response. To conclusively distinguish EBP from EBA, a COL7AI gene mutation analysis was recommended. With a diagnosis of EBP cannot totally rule out EBA, the patient was initially managed with dapsone monotherapy, counseled regarding behavioral modification to reduce scratching and trauma, advised wound care and close monitoring for the development of oropharyngeal lesions, and recommended for COL7A1 genetic mutation analysis.
Conclusion
This report demonstrates a case of EBP
with elevated Anti-Collagen VII antibodies. The
diistinction between EBP and EBA is important
because this changes the management: EBP is
largely supportive, while EBA may benefit from
immunosuppressive therapy.
Epidermolysis Bullosa Pruriginosa
;
Enzyme-Linked Immunosorbent Assay
;
Epidermolysis Bullosa Acquisita